Shionogi and F2G report Phase 3 OASIS results for investigational olorofim in patients with invasive aspergillosis and ...
NUS, ovarian ageing, egg development, reproductive health, fertility research, mechanobiology, SMAD7, granulosa cells, tissue ...
Samsung Biologics raises its 2026 revenue growth outlook to 20% as manufacturing activity supports earnings and its ...
QIAGEN N.V. and EQT XI fund (“EQT Private Equity”) announced an agreement under which Crown NL Bidco B.V. (the “Bidder”) ...
New Zealand based Aroa Biosurgery, a soft tissue regeneration company, has entered into an exclusive agreement with Mölnlycke ...
DOBBS Community and OncoCare connect GP education, digital cancer awareness and specialist referrals to support earlier ...
NovAccel, Inc., a Japanese deep-tech company developing proprietary superconducting accelerator technology for medical ...
Mubadala Bio inks strategic partnership with Marcyrl Group to localise broad portfolio of women’s health in UAE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results